Home / Compliance actions / 638766

FDA Warning Letter — LEXINGTON AVE DRIVE THRU

Case 638766 — FEI 3014663705

The FDA took a Warning Letter action against LEXINGTON AVE DRIVE THRU on Aug 2, 2022 (Mansfield, OH). The action was issued by CTP and concerns tobacco products.

Action details

Facility
LEXINGTON AVE DRIVE THRU
Date
Aug 2, 2022
Fiscal Year
2022
Product Type
Tobacco
Center
CTP
Location
Mansfield, OH (United States)

Facility

Other compliance actions

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.